MIRA

MIRA Pharmaceuticals, Inc. Common Stock

NASDAQ: MIRA · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

$0.98

-2.88% today

Updated 2026-06-03

Market cap

$42.02M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.27

Dividend yield

—

52W range

$1 – $2

Volume

0.1M

Market cap

$42.02M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.27

Dividend yield

—

52W range

$1 – $2

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →199 stocks currently score above 75

Price targets

Analyst target

$17.75

+1720.33%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-1.20M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-7.06M	$-11.98M	$-7.85M	$-10.44M	$-1.15M
EPS	—	—	—	—	$-1.27
Free cash flow	$-5.60M	$-4.53M	$-5.56M	$-4.66M	$-1.20M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
MIRA	$42.02M	18	4.3	3.0	5.0	6.0	—	Avoid
LLY	$1.01T	76	10.0	10.0	4.3	6.0	—	Strong Buy
JNJ	$567.28B	57	4.7	9.0	3.3	6.0	-67.79%	Buy
ABBV	$391.50B	63	4.0	8.0	4.0	5.0	-48.06%	Buy
UNH	$373.28B	54	5.3	5.5	4.0	5.5	-26.94%	Buy
NVS	$289.19B	49	3.3	9.0	3.3	4.5	-65.15%	Hold

Smart narrative

MIRA Pharmaceuticals, Inc. Common Stock trades at $0.98. Our Smart Value Score of 18/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score.

Frequently asked questions

What is MIRA Pharmaceuticals, Inc. Common Stock's stock price?

MIRA Pharmaceuticals, Inc. Common Stock (MIRA) trades at $0.98.

Is MIRA Pharmaceuticals, Inc. Common Stock overvalued?

MIRA Pharmaceuticals, Inc. Common Stock carries a Smart Value Score of 18/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of MIRA Pharmaceuticals, Inc. Common Stock (MIRA)?

The 12-month analyst consensus target is $17.75, about 1720.3% above the current $0.98. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryDRUG MANUFACTURERS - GENERAL

CountryUSA

ExchangeNASDAQ

CurrencyUSD

mirapharmaceuticals.com

Quick metrics

P/S ratio—

ROE-104.92%

Beta1.50

50D MA$1.03

200D MA$1.29

Shares out0.04B

Float0.04B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

MIRA vs LLY →MIRA vs JNJ →MIRA vs ABBV →Stock screener →